Robb Knie Hoth Therapeutics, Inc. (HOTH) insider trading activity

HOTH Quotes by TradingView

Robb Knie is CEO and President of Hoth Therapeutics, Inc.. Currently has a direct ownership of 547,387 shares of HOTH, which is worth approximately $799,185. The most recent transaction as insider was on Aug 28, 2025, when has been sold 310,744 shares (Common Stock) at a price of $1.21 per share, resulting in proceeds of $376,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 547K
841.64% 3M change
841.64% 12M change
Total Value Held $799,185

Robb Knie Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 28 2025
SELL
Payment of exercise price or tax liability
$376,000 $1.21 p/Share
310,744 Reduced 36.21%
547,387 Common Stock
Aug 27 2025
BUY
Grant, award, or other acquisition
-
800,000 Added 48.25%
858,131 Common Stock
Aug 16 2024
BUY
Open market or private purchase
$16,750 $0.67 p/Share
25,000 Added 30.07%
58,131 Common Stock
Sep 19 2022
BUY
Open market or private purchase
$3,900 $0.39 p/Share
10,000 Added 1.19%
828,259 Common Stock
Sep 16 2022
BUY
Open market or private purchase
$4,000 $0.4 p/Share
10,000 Added 1.21%
818,259 Common Stock
RK

Robb Knie

CEO and President
New York, NY

Track Institutional and Insider Activities on HOTH

Follow Hoth Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOTH shares.

Notify only if

Insider Trading

Get notified when an Hoth Therapeutics, Inc. insider buys or sells HOTH shares.

Notify only if

News

Receive news related to Hoth Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HOTH